INOVIO (NASDAQ: INO) announced that results from its Phase 1 proof-of-concept trial evaluating DNA-encoded monoclonal antibodies (DMAbs) for COVID-19 have been published in Nature Medicine. The ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin ...

Abstract: Multi-label text classification involves assigning multiple relevant categories to a single text, enabling applications in academic indexing, medical diagnostics, and e-commerce. However, ...

aState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial ...

Tasha, Julia, and Ezri Mitra's aunt Regine Velasquez encouraged them to form a group as they were all passionate about music and arts.

Abstract: The intelligent identity authentication based on specific emitter identification (SEI) shows great promise in the field of military and civilian. In real-world scenarios, the distribution of ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...

Ferrari has unveiled the SC40, a one-off creation that blends modern engineering with visual nods to the iconic F40.

MASPIN (“tumor suppressor shield”): MASPIN is a natural defense protein that blocks tumor invasion, regulates cell migration and angiogenesis, promotes apoptosis, and enhances treatment sensitivity.